It is now possible to obtain the sequence of all 3 billion nucleotides of an individual’s DNA (the patient’s genome) relatively quickly and at a cost that is decreasing. These and related genetic studies on increasing numbers of patients have helped refine our understanding of the genetic basis of disease. As more patients are studied, clinicians and researchers are collaborating to create databases that can link clinical findings to specific changes in the genome. With these advances, an understanding of genetic principles is becoming an increasingly important part of healthcare. Genetic testing is changing the method of diagnosing certain diseases. It is placing doctors in a better position to understand prognosis and communicate this information to patients and families.
Every year approximately 400,000 babies are born in Texas and receive newborn screening shortly after birth. Join us to learn how the Texas Newborn Screening system functions today and what the future might hold. New technologies have allowed for expansion of conditions detected by newborn screening. As genetic technologies continue to progress the newborn screening system will continue to evolve and bring with it new challenges to science, to clinical care, and new ethical issues. Please join our distinguished speakers to explore the world of newborn screening and genetics.